Koji Hasegawa

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 27

Top Topics

Atrial Fibrillation

Low Density Lipoprotein

Cardiovascular Disease

Top Venues

European heart journal. Cardiovascular pharmacotherapy

European heart journal open

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Jie Jun Wong, Laureen Yi-Ting Wang, Koji Hasegawa, Kay Woon Ho, Zijuan Huang, Louis L Y Teo, Jack Wei Chieh Tan, Kazuyuki Kasahara, Ru-San Tan, Junbo Ge, Angela S Koh
Current frailty knowledge, awareness, and practices among physicians following the 2022 European consensus document on Frailty in Cardiology. European heart journal open 4 (2) (2024)
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Eri Toda Kato, Koji Hasegawa, Koh Ono
The Impact of SGLT2 Inhibitors in Post-Myocardial Infarction Management: Insights from EMPACT-MI and DAPA-MI Trials. European heart journal. Cardiovascular pharmacotherapy (2024)
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Yihong Sun, Koji Hasegawa, Heinz Drexel
Should pharmacotherapy targeting lipoprotein(a) be further expanded for patients with diabetes? European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Yihong Sun, Koji Hasegawa, Heinz Drexel
Should pharmacotherapy targeting lipoprotein(a) be further expanded for patients with diabetes? European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Yihong Sun, Koji Hasegawa, Heinz Drexel
Should pharmacotherapy targeting lipoprotein(a) be further expanded for patients with diabetes? European heart journal. Cardiovascular pharmacotherapy (2024)
Jie Jun Wong, Laureen Yi-Ting Wang, Koji Hasegawa, Kay Woon Ho, Zijuan Huang, Louis L Y Teo, Jack Wei Chieh Tan, Kazuyuki Kasahara, Ru-San Tan, Junbo Ge, Angela S Koh
Current frailty knowledge, awareness, and practices among physicians following the 2022 European consensus document on Frailty in Cardiology. European heart journal open 4 (2) (2024)
Yasuhiro Hamatani, Moritake Iguchi, Keita Okamoto, Yumiko Nakanishi, Kimihito Minami, Kenjiro Ishigami, Syuhei Ikeda, Kosuke Doi, Takashi Yoshizawa, Yuya Ide, Akiko Fujino, Mitsuru Ishii, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao
Association of left atrial enlargement with heart failure events in non-valvular atrial fibrillation patients with preserved left ventricular ejection fraction. European heart journal open 4 (2) (2024)
Yasuhiro Hamatani, Moritake Iguchi, Keita Okamoto, Yumiko Nakanishi, Kimihito Minami, Kenjiro Ishigami, Syuhei Ikeda, Kosuke Doi, Takashi Yoshizawa, Yuya Ide, Akiko Fujino, Mitsuru Ishii, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao
Association of left atrial enlargement with heart failure events in non-valvular atrial fibrillation patients with preserved left ventricular ejection fraction. European heart journal open 4 (2) (2024)
Syuhei Ikeda, Yoshimori An, Moritake Iguchi, Hisashi Ogawa, Yumiko Nakanishi, Kimihito Minami, Kenjiro Ishigami, Yuya Aono, Kosuke Doi, Yasuhiro Hamatani, Takashi Yoshizawa, Yuya Ide, Akiko Fujino, Mitsuru Ishii, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao
Proteinuria is independently associated with heart failure events in patients with atrial fibrillation: The Fushimi AF registry. European heart journal. Quality of care & clinical outcomes (2023)
Moritake Iguchi, Juan Tamargo, Koji Hasegawa
Are NOACs always the best strategy in elderly AF patients? European heart journal. Cardiovascular pharmacotherapy (2023)
Hiroki Shiomi, Koji Hasegawa, Koh Ono
What is optimal DAPT duration after PCI? European heart journal. Cardiovascular pharmacotherapy (2023)
Basil S Lewis, Koji Hasegawa
Factor XIa inhibitors: collecting the clinical evidence. European heart journal. Cardiovascular pharmacotherapy (2023)
Swati Mittal, Maki Komiyama, Yuka Ozaki, Hajime Yamakage, Noriko Satoh-Asahara, Hiromichi Wada, Akihiro Yasoda, Masafumi Funamoto, Yasufumi Katanasaka, Yoichi Sunagawa, Tatsuya Morimoto, Masaharu Akao, Mitsuru Abe, Yuko Takahashi, Takeo Nakayama, Koji Hasegawa
Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan. European heart journal open 4 (1) (2023)
Heinz Drexel, Juan Tamargo, Juan-Carlos Kaski, Basil S Lewis, Christoph H Saely, Peter Fraunberger, Dobromir Dobrev, Maki Komiyama, Thomas Plattner, Stefan Agewall, Koji Hasegawa
Triglycerides Revisited: is Hypertriglyceridaemia a Necessary Therapeutic Target in Cardiovascular Disease? European heart journal. Cardiovascular pharmacotherapy (2023)
Swati Mittal, Maki Komiyama, Yuka Ozaki, Hajime Yamakage, Noriko Satoh-Asahara, Hiromichi Wada, Akihiro Yasoda, Masafumi Funamoto, Yasufumi Katanasaka, Yoichi Sunagawa, Tatsuya Morimoto, Masaharu Akao, Mitsuru Abe, Yuko Takahashi, Takeo Nakayama, Koji Hasegawa
Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan. European heart journal open 4 (1) (2023)
Koji Hasegawa, Takanori Ikeda
Pharmapulse report-does the arrival of factor XI inhibitors mark the end of the NOAC era? European heart journal. Cardiovascular pharmacotherapy 8 (3) (2022)
Masafumi Funamoto, Yoichi Sunagawa, Yasufumi Katanasaka, Toru Kato, Junichi Funada, Yoichi Ajiro, Maki Komiyama, Masaharu Akao, Akihiro Yasoda, Hajime Yamakage, Noriko Satoh-Asahara, Hiromichi Wada, Yasumasa Ikeda, Tatsuya Morimoto, Koji Hasegawa
Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study. European heart journal open 2 (5) (2022)
Akiko Hata, Maki Komiyama, Akihiro Yasoda, Hiromichi Wada, Hajime Yamakage, Noriko Satoh-Asahara, Tatsuya Morimoto, Yuko Takahashi, Koji Hasegawa
Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial. JMIR research protocols 11 (7) (2022)
Juan Tamargo, Koji Hasegawa, Stefan Agewall
Toward personalized medicine for cardiovascular pharmacotherapy. European heart journal 43 (45) (2022)
Maki Komiyama, Stefan Agewall, Koji Hasegawa
Future of antithrombotic therapy for heart failure with coronary artery disease. European heart journal. Cardiovascular pharmacotherapy 8 (5) (2022)
Maki Komiyama, Yuka Ozaki, Hiromichi Wada, Hajime Yamakage, Noriko Satoh-Asahara, Akihiro Yasoda, Yoichi Sunagawa, Tatsuya Morimoto, Shinji Tamaki, null Masahiro Suzuki, Takuo Shibayama, Toru Kato, Yasumasa Okada, Toshiyuki Kita, Yuko Takahashi, Koji Hasegawa
Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan (YiganSan), in smokers with depressive tendencies. BMC complementary medicine and therapies 22 (1) (2022)
Koji Hasegawa, Basil S Lewis
Are SGLT2 inhibitors effective against 'all' heart failure with preserved ejection fraction? European heart journal. Cardiovascular pharmacotherapy 8 (3) (2022)
Juan Tamargo, Juan Carlos Kaski, Takeshi Kimura, Jack Charles Barton, Ko Yamamoto, Maki Komiyama, Heinz Drexel, Basil S Lewis, Stefan Agewall, Koji Hasegawa
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. European heart journal. Cardiovascular pharmacotherapy 8 (7) (2022)
Hisashi Ogawa, Yoshimori An, Hidehisa Nishi, Shunichi Fukuda, Kenjiro Ishigami, Syuhei Ikeda, Kosuke Doi, Yuya Ide, Yasuhiro Hamatani, Akiko Fujino, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Tetsuya Tsukahara, Gregory Y H Lip, Masaharu Akao, null null
Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 23 (9) (2021)